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1607-551X/Copyright ª 2014, KaohsiuAbstract Eosinophils are important inflammatory cells involved in the pathogenesis of
chronic rhinosinusitis with nasal polyps (CRSwNP). Vitamin D and its derivatives, in addition
to their classic role as regulators of electrolytes homeostasis, have modulatory effects in
immunological and inflammatory responses. Such properties suggest that vitamin D might also
play a role in inflammatory airway diseases such as CRSwNP. In this study, we investigated the
effect of vitamin D derivatives (calcitriol and tacalcitol) on the secretion of eotaxin and Regu-
lated on Activation, Normal T Cell Expressed and Secreted (RANTES), the two major eosinophil
chemoattractants, in fibroblasts derived from the polyps of Taiwanese CRSwNP patients. Pa-
tients diagnosed with eosinophilic CRSwNP but without malignancies or asthma and undergoing
elective endoscopic sinus surgery were recruited. Three primary fibroblast cultures were es-
tablished using the polyp specimens obtained from these patients. The third to eighth passages
of the fibroblasts were used for in vitro studies. Nasal polyp-derived fibroblasts were stimu-
lated with IL-1b (10 ng/mL) for 24 hours, followed by replacement with media alone or with
calcitriol or tacalcitol (10mM) and incubation for another 24 hours. After the treatments, theeclare no conflicts of interest.
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64 L.-F. Wang et al.levels of secreted eotaxin and RANTES were evaluated by ELISA assays. The results showed that
IL-1b could substantially stimulate the secretion of eotaxin (p < 0.01) and RANTES (p < 0.01) in
nasal polyp-derived fibroblasts. More importantly, this stimulatory effect was significantly sup-
pressed by adding calcitriol (p  0.002 for eotaxin and p  0.008 for RANTES) or tacalcitol
(p  0.009 for eotaxin and p  0.02 for RANTES). Therefore, the inhibitory effect of vitamin
D derivatives on eotaxin and RANTES secretion might shed light not only on the disease mech-
anism, but also on the potential use of vitamin D in pharmacotherapy of Taiwanese patients
with CRSwNP.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an in-
flammatory disease of the upper airway. Although its eti-
ology and pathophysiology are still controversial, CRSwNP is
believed to be the manifestation of complex inflammatory
reactions [1]. Currently, topical steroids are the most
commonly used therapeutic agents for CRSwNP, which are
generally safe and well tolerated despite the inconsistent
effects. Besides, other forms of antiinflammatory and
antiproliferative agents are being intensively evaluated [2].
However, the result is still unsatisfactory, and, because of
frequent recurrence, repeated surgical interventions are
often necessary.
Many cytokines and chemokines are thought to promote
the pathogenesis of CRSwNP by facilitating the recruitment
of inflammatory cells into the airway. Accumulation of
eosinophils is one of the most characteristic features of
CRSwNP. The degree of mucosal eosinophilia is correlated
with more extensive disease and a decreased likelihood of
surgical success [3,4]. Regulated on Activation, Normal T
Cell Expressed and Secreted (RANTES) (CCL 5) and eotaxin
(CCL11) are two potent eosinophil-specific chemokines that
contribute to chronic inflammation in CRSwNP. RANTES is a
member of the C-C family of chemokines originally cloned
from a subtracted cDNA library made from isolated RNA of a
functional, nontransformed antigen-stimulated T cell line
[5]. RANTES has been shown to induce cutaneous eosinophil
infiltration when injected into dogs [6] and humans [7].
More importantly, there is a report that RANTES can induce
eosinophil influx into the nasal mucosa [8]. The effects of
RANTES on eosinophils include chemotaxis, induction of
transendothelial migration and reactive oxygen species,
and release of eosinophil cationic protein (ECP) [9,10]. By
reviewing the literature, we found that RANTES immuno-
reactivity could be detected in nasal polyp specimens, and
was localized predominantly to the epithelial [11] or
endothelial cells [12]. Meyer et al. [13] speculated that
RANTES played a key role in the mobilization of eosinophils
into nasal polyp tissues. Moreover, Saji et al. [14] demon-
strated the production of RANTES from nasal polyp fibro-
blasts after stimulation with IL-1b. It was suggested that IL-
1b-induced production of RANTES in nasal polyp fibroblasts
was necessary for eosinophil infiltration.
Eotaxin, also a member of the C-C family of chemokines,
is a potent eosinophil attractant and can induce eosinophilrecruitment and activation. It plays an indirect role in
airway remodeling through recruitment of eosinophils and
mast cells, which have profibrogenic and proangiogenic
activities, into the site of inflammation [15]. Yao et al. [16]
reported that eotaxin immunoreactivity was observed in
most of the infiltrating eosinophils, among other eotaxin-
positive inflammatory cells, and in epithelial and endo-
thelial cells of nasal polyps. Furthermore, Yoshifuku et al.
[17] showed that nasal polyp-derived fibroblasts could
secrete eotaxin in the presence of proinflammatory medi-
ators. Their findings suggested a critical effect of eotaxin
on the selective recruitment of eosinophils in nasal polyps.
Vitamin D is known to regulate calcium and bone ho-
meostasis. However, increasing recent evidence has
revealed diverse physiological functions of vitamin D de-
rivatives, including the immunomodulatory, anti-
proliferative, and antiinflammatory effects. Several studies
have indicated the function of vitamin D in the pathogen-
esis and manifestation of airway diseases [18e20]. For
example, vitamin D deficiency is related to the severity of
asthma [18,21]. Maternal vitamin D intake from foods dur-
ing pregnancy may be negatively associated with the risk of
asthma and allergic rhinitis in childhood [22]. Furthermore,
in cultured cell models, vitamin D derivatives could inhibit
the proliferation of, and downregulate RANTES production
in, nasal polyp-derived fibroblasts from Caucasian patients
with CRSwNP [23,24]. Although there are several recent
reports indicating that vitamin D deficiency is correlated
with disease severity and acts as a major player in the
immunopathology of CRSwNP [25e27], whether vitamin D
might influence tissue eosinophilia of CRSwNP by modu-
lating eotaxin and RANTES secretion especially in Asian
patients is not clear and warrants further investigation.Materials and methods
Patients and tissues
This study was approved by the Institutional Review Board
of Kaohsiung Medical University Hospital, Kaohsiung,
Taiwan (KMUH-IRB-990427), and written informed consent
was obtained from each participant prior to the study.
Based on the definition in European Position Paper on
Rhinosinusitis and Nasal Polyps (EPOS) 2007 [28], patients
with recent diagnosis of CRSwNP undergoing elective
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Patients with malignancies or asthma were excluded from
the study. All patients were asked to stop antiin-
flammatory medications, including antibiotics and topical
steroids, for at least 2 weeks prior to admission. The tis-
sues were isolated from the polyps of CRSwNP patients
during the operations. The tissue sections were fixed in
formalin and stained with hematoxylin, and the number of
eosinophil was counted at 200  magnification under a
light microscope. The definition of eosinophilic nasal
polyps was similar to that described by Yoshifuku et al.
[17]. In brief, five fields were examined for each section
from which the average number [per high power field
(HPF)] of eosinophil infiltration in the sample was deter-
mined. Those with >100 eosinophils/HPF and <10 eosin-
ophils/HPF were considered as eosinophilic and
noneosinophilic nasal polyps, respectively. Both eosino-
philic and noneosinophilic polyp tissues were derived into
primary fibroblast cultures, in which only the former was
used for vitamin D treatment.
Reagents
IL-1b was purchased from Sigma-Aldrich (I9401; St. Louis,
MO, USA). Calcitriol and tacalcitol were obtained from
Tocris Bioscience (Ellisville, MO, USA). Human eotaxin and
RANTES Quantikine ELISA kits were purchased from R&D
Systems (Minneapolis, MN, USA).
Primary culture of nasal polyp-derived fibroblasts
The obtained tissues were washed three times with anti-
biotics containing Hank’s Balanced Salt Solution (HBSS)
and cut into small pieces (1 mm3). The tissue explants
were treated with 0.5% trypsin for 7 minutes at 37C,
followed by neutralization with serum-containing Dul-
becco’s modified Eagle’s medium (DMEM). After washing
three times with HBSS, the explants were plated into 6-
well culture dishes CellBIND Surface (product #3337,
Corning, New York) and cultured with DMEM medium and
with 10% FBS in a 37C, 5% CO2 humidified incubator for
about 2 weeks. When the primary culture reached
confluence at 70e80%, the nasal fibroblasts were sub-
cultured into 10-cm dishes. Nasal fibroblasts at the third
to eighth passages were used in the following
experiments.
ELISA assays of eotaxin and RANTES
Nasal polyp-derived fibroblasts (5  104) were cultured in
each well of a 96-well plate with serum-containing or
serum- and IL-1b-containing (10 ng/mL) medium for 24
hours. Subsequently, the medium of IL-1b-treated groups
was replaced with fresh serum-free medium alone or
together with calcitriol or tacalcitol (10mM), while the
medium of mock-treated group was replaced with serum-
free medium. One day later, the concentrations of
secreted eotaxin and RANTES in the culture supernatants
were determined by ELISA Human Eotaxin and RANTES
Quantikine ELISA kit (R&D Systems, Minneapolis, MN)
based on the manufacturer’s instructions. The opticaldensity was read at 450 nm using a microplate reader, and
the concentrations were calculated by interpolation from
a standard curve. All experiments were done in triplicate
and the results were expressed as mean  SD.
Statistical analysis
The results of ELISA assays were analyzed by one-way
analysis of variance (one-way ANOVA) followed by least
significant difference (LSD) post hoc comparison of the
treatments of mock versus IL-1b, IL-1b versus IL-1bþ
calcitriol, and IL-1b versus IL-1bþ tacalcitol, in which
p < 0.05 was considered statistically significant.
Results
Vitamin D inhibited IL-1b-induced secretion of
eotaxin
To determine the potential therapeutic effect of vitamin D
in alleviating tissue eosinophilia in nasal polyps, we exam-
ined whether calcitriol, an active form of vitamin D, and
tacalcitol, a vitamin D derivative, could inhibit eotaxin
secretion in nasal polyp-derived fibroblasts. Three inde-
pendent cases of the fibroblast primary cultures from three
patients with eosinophilic CRSwNP were established.
Eotaxin was first induced by IL-1b (10 ng/mL) for 24 hours,
followed by the treatment of calcitriol or tacalcitol (10mM)
for another 24 hours. The levels of eotaxin in culture media
were measured using ELISA assay. Analysis with one-way
ANOVA indicated significant difference among the treat-
ments (p < 0.001 in all cases). Further analysis with LSD
post hoc comparison revealed significant differences be-
tween mock and IL-1b (16.82  1.93 pg/mL vs.
39.24  2.1 pg/mL in Case #1, p < 0.001; 21.85  2.47 pg/
mL vs. 47.41  2.25 pg/mL in Case #2, p < 0.01; and
16.97  0.98 pg/mL vs. 37.93  2.34 pg/mL in Case #3,
p < 0.001). This IL-1b-induced secretion of eotaxin was
significantly suppressed with the addition of calcitriol
(39.24  2.1 pg/mL vs. 23.22  1.48 pg/mL in Case #1,
p < 0.001; 47.41  2.25 pg/mL vs. 33.83  0.92 pg/mL in
Case #2, p Z 0.002; and 37.93  2.34 pg/mL vs.
23.15  0.99 pg/mL in Case #3, p < 0.001) or tacalcitol
(39.24  2.1 pg/mL vs. 25.42  1.27 pg/mL in Case #1,
p < 0.001; 47.41  2.25 pg/mL vs. 30.49  1.58 pg/mL in
Case #2, p Z 0.009; and 37.93  2.34 pg/mL vs.
23.47  0.74 pg/mL in Case #3, p < 0.001; Fig. 1).
Vitamin D inhibited IL-1b-induced secretion of
RANTES
We next investigated how vitamin D would influence
RANTES secretion in nasal polyp-derived fibroblasts using
the same approach. Analysis with one-way ANOVA on the
ELISA results revealed significant difference among the
treatments (p < 0.01 in all cases). Further analysis with LSD
post hoc comparison showed that, in both primary cultures,
RANTES was dramatically induced by IL-1b
(32.47  0.24 pg/mL vs. 54.69  1.92 pg/mL in Case #1,
p Z 0.004; 34.29  3.16 pg/mL vs. 56.68  2.94 pg/mL in
Figure 1. Inhibition of IL-1b-induced eotaxin secretion by vitamin D in nasal polyp-derived fibroblasts. Three cases (A, B, and C)
of primary culture were treated with IL-1b alone, or IL-1b followed by calcitriol or tacalcitol. Secretion of eotaxin into the culture
media was measured by ELISA assay. Addition of the vitamin D derivatives resulted in decreased level of IL-1b-induced eotaxin
secretion. All experiments were done in triplicate and expressed as mean  SD. A p value <0.05 represented statistical
significance.
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26.47  1.15 pg/mL in Case #3, p < 0.001). Such induction
of RANTES was significantly suppressed in the presence of
calcitriol (54.69  1.92 pg/mL vs. 41.15  1.6 pg/mL in
Case #1, p Z 0.008; 56.68  2.94 pg/mL vs.
30.72  3.83 pg/mL in Case #2, p Z 0.008; and
26.47  1.15 pg/mL vs. 16.85  1.34 pg/mL in Case #3,
p < 0.001) or tacalcitol (54.69  1.92 pg/mL vs.
38.72  1.84 pg/mL in Case #1, pZ 0.02; 56.68  2.94 pg/
mL vs. 32.64  2.63 pg/mL in Case #2, p Z 0.01; and
26.47  1.15 pg/mL vs. 16.61  0.11 pg/mL in Case #3,
p < 0.001; Fig. 2). Together, these results suggest that
vitamin D can effectively inhibit eotaxin and RANTES
secretion in nasal polyp-derived fibroblasts.Discussion
Nasal polyposis remains one of the most challenging and
recalcitrant diseases in clinical rhinology because of its
complex etiology and predisposition to recurrence. How-
ever, it is well established that eotaxin and RANTES are
central to tissue eosinophilia during nasal polyp formation
[13,29,30]. We have previously shown that the serum levelof 25-hydroxyvitamin D (25OHD), the major circulating form
of vitamin D, in CRSwNP patients were significantly lower
than those in chronic rhinosinusitis without nasal polyps
(CRSsNP) patients [27]. Moreover, serum 25OHD level was
significantly and inversely related to the size of nasal
polyps. As vitamin D contains immunomodulatory effects on
various immune cells [31,32], it is surmised that a low
vitamin D level might be unable to attenuate cytokine
release from inflammatory cells, leading to constitutive
activation of inflammatory cascade in nasal polyps.
A previous study by Rostkowska-Nadolska et al. [23]
demonstrated a significant dose-dependent decrease in
the proliferation of nasal polyp-derived fibroblasts after the
cells were treated with various doses of calcitriol and
tacalcitol. Further investigation by the authors revealed
that calcitriol and tacalcitol inhibited the synthesis of the
proinflammatory cytokines IL-6 and IL-8 in the fibroblast
cultures [33]. In this study, we hypothesized that vitamin D
would affect tissue eosinophilia of Taiwanese patients with
CRSwNP through regulating the production of eotaxin and
RANTES. IL-1b is a cytokine with a wide spectrum of
proinflammatory functions. In addition, recruitment of the
inflammatory cells to the inflamed tissues involves a series
of events including adhesion to endothelial cells,
Figure 2. Inhibition of IL-1b-induced RANTES secretion by vitamin D in nasal polyp-derived fibroblasts. Three cases (A, B, and C)
of primary culture were treated with IL-1b alone, or IL-1b followed by calcitriol or tacalcitol. Secretion of RANTES into the culture
media was measured by ELISA assay. Addition of the vitamin D derivatives resulted in decreased level of IL-1b-induced RANTES
secretion. All experiments were done in triplicate and expressed as mean  SD. A p value <0.05 represented statistical
significance.
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movement. These processes are regulated through the
release of inflammatory mediators and cytokines. However,
eotaxin and RANTES are of particular significance for
eosinophil recruitment and infiltration. Thus, we used IL-1b
to induce eotaxin and RANTES production and asked
whether such induction could be inhibited by vitamin D
treatment in nasal polyp-derived fibroblasts. Indeed, the
ELISA results showed that IL-1b could significantly induce
the secretion of eotaxin and RANTES from the nasal fibro-
blasts, and this biological effect was significantly sup-
pressed by the addition of calcitriol or tacalcitol. However,
the mechanism behind the suppression of eotaxin and
RANTES secretion by vitamin D is currently unknown.
Whether vitamin D could block the intracellular synthesis of
eotaxin and RANTES, either at the transcriptional or post-
transcriptional level, or the release process of eotaxin and
RANTES into the media deserves further study. Given that
eotaxin and RANTES promote recruitment of eosinophils
into the polyp microenvironment, the antiinflammatory
effect of vitamin D against nasal polyps might be mediated
through the inhibition of eotaxin and RANTES secretion. A
more detailed study is ongoing.The definition of mucosal eosinophilia in CRSwNP is still
debatable and could be population-dependent. Soler et al.
[34] used a cutoff of more than five eosinophils/high power
field (HPF) to define clinically relevant mucosal eosinophilia
based on in vivo evidence of eosinophil activation. They
also observed the impact of eosinophilia on quality-of-life
outcomes at a higher density (>10 eosinophils/HPF) [35].
In this study, we employed a high standard of >100 eosin-
ophils/HPF to define eosinophilic nasal polyps, ensuring the
inducibility of eotaxin and RANTES in fibroblasts derived
from such polyp tissues. Indeed, the three cases of fibro-
blast cultures used as the cell model were all derived from
eosinophilic polyps, in which eotaxin and RANTES could be
significantly induced by IL1-b. By contrast, these two che-
mokines could not be induced by IL1-b in fibroblasts derived
from the polyp tissues of two noneosinophilic CRSwNP pa-
tients (Figures S1 and S2), indicating that vitamin D is a
potential therapeutic agent specifically for eosinophilic
nasal polyps. Interestingly, nasal polyps in the Asian popu-
lation are suggested to be biased toward neutrophilic
inflammation with less eosinophilia, in contrast to an
eosinophil bias in the Belgian (white) population [36].
However, a recent study showed that plasma RANTES and
68 L.-F. Wang et al.eotaxin levels were significantly elevated and correlated
with disease severity in Taiwanese patients with CRSwNP
[37]. The authors concluded that eotaxin and RANTES could
play a role in enhancing eosinophil recruitment into the
lamina propria of nasal polyps. Therefore, even though
eosinophilia is less prominent in the Asian population with
nasal polyps, eosinophils might still be essential for the
pathogenesis of nasal polyps in Taiwanese patients. Based
on our and others’ results, a possible mechanism for tissue
eosinophilia in CRSwNP is that the proinflammatory cyto-
kines induce eotaxin and RANTES secretion from nasal polyp
fibroblasts, in turn selectively recruiting eosinophils from
the circulation and resulting in eosinophilic infiltration and
inflammation.
Our findings suggest that in patients with vitamin D
deficiency, the inability of low vitamin D level to counter
the secretion of eotaxin and RANTES might lead to chronic
inflammation and eosinophilia characteristic of nasal
polyps. Still, there are limitations in the present study. For
example, the in vitro cell model might not completely
reflect in vivomechanisms. However, we thought that nasal
polyp-derived fibroblasts are a legitimate in vitro model for
this study for three reasons: (1) fibroblasts are an important
component of the ground substances in nasal polyps and
involved in a variety of inflammatory responses associated
with disease pathogenesis [1]; (2) fibroblasts are one of the
major stromal cells that produce and secret eotaxin and
RANTES; and (3) several published studies had used nasal
polyp-derived fibroblasts as the cell model for tissue
remodeling mechanism and therapeutic applications in
nasal polyps [38,39].
In conclusion, this is the first study that investigates the
effect of vitamin D on the production of eotaxin and
RANTES in Taiwanese patients with CRSwNP. We showed
that vitamin D derivatives could significantly inhibit eotaxin
and RANTES secretion in nasal polyp-derived fibroblasts.
These results may not only shed light on the mechanism of
nasal polyp pathogenesis, but warrant further investigation
for the clinical application of vitamin D in pharmacotherapy
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